We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
-$248M
Cap. Flow
-$400M
Cap. Flow %
-32.99%
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223

Top Buys

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$16.2M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$15.8M
3
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
+$12.7M
4
NBL
Noble Energy, Inc.
NBL
+$11.9M
5
SLP icon
Simulations Plus
SLP
+$10.6M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$16M
2
BLUE
bluebird bio
BLUE
+$12.2M
3
BHP icon
BHP
BHP
+$10.7M
4
ALLO icon
Allogene Therapeutics
ALLO
+$8.56M
5
WTW icon
Willis Towers Watson
WTW
+$6.59M

Sector Composition

Rank Sector Weight
1 Healthcare 13.03%
2 Technology 7.51%
3 Consumer Discretionary 5.23%
4 Financials 5.2%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAC icon
176
PUT
KLA
KLAC
$275B
$1.46M 0.12%
75,000
+22,000
+42% +$435K
AMZN icon
177
Amazon
AMZN
$2.5T
$1.44M 0.12%
9,000
+6,100
+210% +$962K
BWA icon
178
BorgWarner
BWA
$13.2B
$1.44M 0.12%
+42,615
New +$1.47M
UA icon
179
Under Armour Class C
UA
$2.92B
$1.44M 0.12%
+145,345
New +$1.36M
EWY icon
180
iShares MSCI South Korea ETF
EWY
$21.7B
$1.44M 0.12%
+22,006
New +$1.38M
LGF.B
181
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$1.42M 0.12%
+161,290
New +$1.29M
OUT icon
182
Outfront Media
OUT
$5.64B
$1.39M 0.11%
94,620
+65,462
+225% +$979K
ACGL icon
183
Arch Capital
ACGL
$36.1B
$1.37M 0.11%
46,579
+36,106
+345% +$1.1M
OBIO icon
184
Orchestra BioMed
OBIO
$224M
$1.36M 0.11%
+125,000
New +$1.4M
JNJ icon
185
PUT
Johnson & Johnson
JNJ
$635B
$1.35M 0.11%
9,100
-8,900
-49% -$1.32M
FBP icon
186
First Bancorp
FBP
$4.4B
$1.35M 0.11%
257,349
+140,901
+121% +$784K
LAZR
187
DELISTED
Luminar Technologies
LAZR
$1.34M 0.11%
7,661
+4,328
+130% +$728K
TXN icon
188
CALL
Texas Instruments
TXN
$255B
$1.33M 0.11%
9,400
-9,400
-50% -$1.28M
MRSN
189
DELISTED
Mersana Therapeutics
MRSN
$1.31M 0.11%
+2,804
New +$1.42M
TRU icon
190
TransUnion
TRU
$14.8B
$1.31M 0.11%
+15,436
New +$1.33M
CLOV icon
191
Clover Health Investments
CLOV
$2.28B
$1.3M 0.11%
+99,999
New +$1.11M
ORPH
192
DELISTED
Orphazyme A/S
ORPH
$1.3M 0.11%
+128,844
New +$1.29M
ASML icon
193
PUT
ASML
ASML
$675B
$1.29M 0.11%
3,500
-1,500
-30% -$561K
RUN icon
194
Sunrun
RUN
$2.37B
$1.28M 0.11%
+16,698
New +$786K
BFH icon
195
Bread Financial
BFH
$4.21B
$1.28M 0.11%
+37,817
New +$1.34M
PBR icon
196
Petrobras
PBR
$121B
$1.25M 0.1%
177,541
+141,952
+399% +$1.21M
ADI icon
197
PUT
Analog Devices
ADI
$181B
$1.24M 0.1%
10,600
-14,100
-57% -$1.65M
LI icon
198
Li Auto
LI
$12.6B
$1.22M 0.1%
+68,900
New +$1.15M
GS icon
199
PUT
Goldman Sachs
GS
$313B
$1.19M 0.1%
5,900
-13,300
-69% -$2.71M
NCNO icon
200
nCino
NCNO
$1.81B
$1.19M 0.1%
+15,000
New +$1.2M
6 7
8
9 10

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.

  • Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
  • Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
  • Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
  • Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
  • Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
  • Maven Securities opened 297 new positions and closed 223 in Q3 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.